Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/MABWELL-SHANGHAI-BIOSCIEN-149076099/nieuws/Mabwell-kondigt-aan-dat-de-Denosumab-oplossing-voor-injectie-door-de-National-Medical-Products-Admin-43412836/?utm_source=whatsapp&utm_medium=social&utm_campaign=share